NNNN - Anbio Biotechnology
22.89
1.090 4.762%
Share volume: 54,490
Last Updated: 03-06-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$21.80
1.09
0.05%
Summary score
8%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
20%
Sector
Manufacturing
Industry
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over timeo
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NNNN | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | 0% | -436.07% | 30.89% | 2.91% |
| Return on assets | 0% | 7.33% | 3.57% | 2.85% |
| Return on sales | 0% | 22.12% | 14.33% | 16.24% |
| Return on invested capital | 0% | 28.28% | 7.87% | 2.94% |
| Profitability | 0% | 75% | 60% | 33% |
| Total debt ratio | 0% | 98.27% | 96.96% | 48.06% |
| Debt ratio change over time | 0% | 0% | 15.51% | 0% |
| Dept financing | 0% | 25% | 50% | 12% |
| Current Ratio | 0% | 1.02% | 2.62% | 1.74% |
| Quick Ratio | 0% | 0.7% | 2.14% | 1.27% |
| Cash Position Ratio | 0% | 0.15% | 1.36% | 0.46% |
| Liquididy | 0% | 15% | 64% | 75% |
| Short-term ratios | NNNN | IDXX | LNTH | QDEL |
|---|---|---|---|---|
| Return on equity | 0% | 65.8% | 3.84% | 6.55% |
| Return on assets | 0% | 7.82% | 1.58% | 5.3% |
| Return on sales | 0% | 23.49% | 5.83% | 29.42% |
| Return on invested capital | 0% | 23.76% | 2.44% | 7.3% |
| Profitability | 0% | 95% | 14% | 52% |
| Total debt ratio | 0% | 89.78% | 64.68% | 38.36% |
| Debt ratio change over time | 0% | 0% | 19.55% | 0% |
| Dept financing | 0% | 25% | 43% | 11% |
| Current Ratio | 0% | 1.02% | 2.62% | 1.74% |
| Quick Ratio | 0% | 0.7% | 2.14% | 1.27% |
| Cash Position Ratio | 0% | 0.15% | 1.36% | 0.46% |
| Liquididy | 0% | 21% | 75% | 40% |